Shinobi Therapeutics

0 followers

‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, US

Employees

11-50

Links

Org chart

Dan Kemp

Chief Executive Officer

Dan Kemp

Collapse

Bhanu Iyer

VP US Operations & HR

Ryosuke Gonotsubo

Chief Of Staff

Teams

This company has no teams yet

Similar companies

Capricor Therapeutics

1 follower

Regeneron

91 followers

Natera

13 followers

AbbVie

168 followers

Moderna Therapeutics

104 followers

MilliporeSigma

2 followers

FUJIFILM Cellular Dynamics

1 follower

Elanco

20 followers

Xencor

1 follower

Anthropic

52 followers

Fashion Institute of Technology

11 followers

Explore companies